Loading clinical trials...
Loading clinical trials...
The purpose of this study is to identify genetic variations in survivors of testicular cancer and connect these variations to differences in risks of late effects.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Rigshospitalet, Denmark
NCT01453660 · Germ Cell Cancer
NCT07662200 · Germ Cell Cancer
NCT07401316 · Germ Cell Cancer Metastatic
NCT02433197 · Testicular Germ Cell Cancer
NCT04402593 · Relapsed Germ Cell Cancer, Cisplatin Induced Tinnitus
Dept. of Oncology, Rigshospitalet
Copenhagen
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions